BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, Wani S, Siddiqi M. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genetics and Cytogenetics 2010;203:263-8. [DOI: 10.1016/j.cancergencyto.2010.08.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Garde-García H, Redondo-González E, Maestro-de Las Casas M, Fernández-Pérez C, Moreno-Sierra J. Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications. Clin Transl Oncol 2021;23:840-5. [PMID: 32839927 DOI: 10.1007/s12094-020-02476-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lipunova N, Wesselius A, Cheng KK, van Schooten FJ, Cazier JB, Bryan RT, Zeegers MP. Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer. Biomark Cancer 2019;11:1179299X19897255. [PMID: 31908559 DOI: 10.1177/1179299X19897255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu J, Wang H, Ricketts CJ, Yang Y, Merino MJ, Zhang H, Shi G, Gan H, Linehan WM, Zhu Y, Ye D. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease. Cancer 2019;125:1060-9. [PMID: 30548481 DOI: 10.1002/cncr.31908] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
4 Zhang L, Wang Y, Qin Z, Li R, Cong R, Ji C, Meng X, Wang Y, Xia J, Song N. TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status. J Cancer 2018;9:3522-31. [PMID: 30310509 DOI: 10.7150/jca.26264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Akhter N, Dar SA, Chattopadhyay S, Haque S, Anwer R, Wahid M, Jawed A, Lohani M, Mandal RK, Shukla NK, Abdul Y, Husain SA. Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population. Curr Genomics 2018;19:395-410. [PMID: 30065615 DOI: 10.2174/1389202919666171205104137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Mandal RK, Yadav SS, Panda AK. No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis. Tumor Biol 2014;35:8607-13. [DOI: 10.1007/s13277-014-2114-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
7 Thurow HS, Hartwig FP, Alho CS, Silva DS, Roesler R, Abujamra AL, de Farias CB, Brunetto AL, Horta BL, Dellagostin OA, Collares T, Seixas FK. Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs. Mol Biol Rep 2013;40:4929-34. [PMID: 23661019 DOI: 10.1007/s11033-013-2593-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
8 Sameer AS. Colorectal cancer: a researcher’s perspective of the molecular angel’s gone eccentric in the Vale of Kashmir. Tumor Biol 2013;34:1301-15. [DOI: 10.1007/s13277-013-0692-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
9 Liu ZH, Bao ED. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk. Mol Biol Rep 2013;40:2389-95. [PMID: 23184052 DOI: 10.1007/s11033-012-2319-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Yang Z, Nie S, Zhu H, Wu X, Jia S, Luo Y, Tang W. Association of p53 Arg72Pro polymorphism with bladder cancer: a meta-analysis. Gene 2013;512:408-13. [PMID: 23073555 DOI: 10.1016/j.gene.2012.09.085] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
11 Pandith AA, Khan NP, Rashid N, Azad N, Zaroo I, Hafiz A, Siddiqi MA. Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir. Tumour Biol 2012;33:927-33. [PMID: 22249977 DOI: 10.1007/s13277-012-0318-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
12 Huang C, Su C, Chu J, Huang S, Pu Y, Yang H, Chung C, Wu C, Hsueh Y. The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area. Toxicology and Applied Pharmacology 2011;257:349-55. [DOI: 10.1016/j.taap.2011.09.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
13 Thurow HS, Haack R, Hartwig FP, de Oliveira IO, Dellagostin OA, Gigante DP, Horta BL, Collares T, Seixas FK. TP53 gene polymorphism: Importance to cancer, ethnicity and birth weight in a Brazilian cohort. J Biosci 2011;36:823-31. [DOI: 10.1007/s12038-011-9147-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]